Variables | Mean ± SD Placebo(n = 28) | Mean ± SD Ellagic acid (n = 29) | P1 | |
---|---|---|---|---|
Chol(mg/dL) | Baseline | 192 ± 51.03 | 197.13 ± 48.71 | 0.801 |
End | 190.28 ± 58.51 | 178.09 ± 45.46 | 0.024 | |
P2 | 0.754 | 0.0349 | Â | |
Mean Changes | -1.72 ± 7.48 | -19.04 ± 3.25 | 0.031 | |
TG (mg/dL) | Baseline | 159.19 ± 19.61 | 163.28 ± 20.55 | 0.586 |
End | 157.2 ± 19.29 | 145.33 ± 16.04 | 0.042 | |
P2 | 0.59 | 0.04 | Â | |
Mean Changes | -1.99 ± 0.32 | -17.95 ± 4.51 | 0.043 | |
HDL (mg/dL) | Baseline | 37.08 ± 6.27 | 36.13 ± 7.7 | 0.55 |
End | 37 ± 6.25 | 39.2 ± 8.02 | 0.124 | |
P2 | 0.61 | 0.082 | Â | |
Mean Changes | -0.08 ± 0.02 | 3.07 ± 0.32 | 0.23 | |
LDL (mg/dL) | Baseline | 123.08 ± 40.05 | 128.34 ± 36.89 | 0.714 |
End | 122.28 ± 44.11 | 108.7 ± 35.19 | 0.04 | |
P2 | 0.8 | 0.031 | Â | |
Mean Changes | -0.8 ± 4.06 | -19.64 ± 1.7 | 0.044 |